New hep C drugs: GPs concerned over lack of detail

GPs are keen to join a new training program allowing them to prescribe a new generation of hepatitis C superdrugs to be listed on the PBS from 1 March.

But the lack of detailed information for GPs, allied health professionals and even pharmacists is leading to concerns of possible delays and treatment bottlenecks in achieving a mass rollout.

Hepatitis C is one of Australia’s largest public health problems. An estimated 230,000 patients have the disease, 10,000 new cases are reported annually, and it is responsible for up to 700 primary liver cancer